Alignment Healthcare, Inc.
8.06USD
-0.3700 (-4.39%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ALHC.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.04▼ | $0.14 | 0 | 0 |
| Next quarter | $0.04▲ | $0.01 | 0 | 0 |
| Current year | $0.45▼ | $0.48 | 0 | 0 |
| Next year | $0.65▼ | $0.72 | 0 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.2 | $0.25 | +0.05 (+24.3%) |
| 2026-03-31 | $0.09 | $0.12 | +0.03 (+38.7%) |
| 2025-12-31 | -$0.08 | -$0 | +0.08 (+98.2%) |
| 2025-09-30 | -$0.01 | $0.1 | +0.11 (+1081.0%) |
101 ratings from 16 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $22 $9 | Oct 12, 2026 |
| TD Cowen | Maintained | Buy | $21 $12 | Oct 12, 2026 |
| William Blair | Downgraded from Outperform | Market Perform | — | Oct 9, 2026 |
| JP Morgan | Maintained | Overweight | $22 $10 | Oct 9, 2026 |
| Keybanc | Maintained | Overweight | $28 $12 | Oct 9, 2026 |
| Barclays | Maintained | Equal-Weight | $16 $10 | Oct 6, 2026 |
| JP Morgan | Maintained | Overweight | $26 $22 | Aug 4, 2026 |
| Raymond James | Downgraded from Strong Buy | Outperform | $22 $19 | Aug 3, 2026 |
| Barclays | Maintained | Equal-Weight | $19 $16 | May 26, 2026 |
| UBS | Maintained | Neutral | $21 $22 | May 1, 2026 |
| Barclays | Maintained | Equal-Weight | $18 $19 | May 1, 2026 |
| JP Morgan | Maintained | Overweight | $23 $26 | Feb 5, 2026 |
| TD Cowen | Maintained | Buy | $18.5 $25 | Jan 16, 2026 |
| UBS | Maintained | Neutral | $18 $21 | Jan 14, 2026 |
| Piper Sandler | Maintained | Overweight | $20 $30 | Jan 6, 2026 |
| JP Morgan | Maintained | Overweight | $20 $23 | Dec 17, 2025 |
| JP Morgan | Upgraded from Neutral | Overweight | $18 $20 | Nov 24, 2025 |
| JP Morgan | Maintained | Neutral | $17 $18 | Nov 5, 2025 |
| Barclays | Maintained | Equal-Weight | $13 $18 | Nov 3, 2025 |
| UBS | Maintained | Neutral | $17 $18 | Oct 31, 2025 |
| Goldman Sachs | Initiated | Buy | $21 | Oct 14, 2025 |
| Keybanc | Upgraded from Sector Weight | Overweight | $21 | Aug 25, 2025 |
| Barclays | Upgraded from Underweight | Equal-Weight | $9 $13 | Jul 31, 2025 |
| UBS | Maintained | Neutral | $16 $17 | May 2, 2025 |
| Baird | Maintained | Outperform | $17 $22 | Apr 15, 2025 |
159 filings from 26 insiders · 6 buy / 17 sell over 6m
Officers and directors of ALHC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Kim HyongOfficer, Chief Medical Officer | Sell | 32.5k | $8.30 | $270k | Oct 6, 2026 |
| KONOWIECKI JOSEPH SDirector; Officer, EVP, Corporate Affairs | Sell | 23.5k | $8.61 | $202k | Sep 17, 2026 |
| KAO JOHN EDirector; Officer, Chief Executive Officer | Sellindirect | 27.4k | $13.00 | $356k | Sep 14, 2026 |
| Maroney Dawn ChristineOfficer, President | Sell | 122.7k | $12.68 | $1.56M | Sep 11, 2026 |
| KAO JOHN EDirector; Officer, Chief Executive Officer | Sell | 385.3k | $12.68 | $4.89M | Sep 11, 2026 |
| KAO JOHN EDirector; Officer, Chief Executive Officer | Sellindirect | 172.6k | $12.96 | $2.24M | Sep 10, 2026 |
| MARONEY DAWN CHRISTINEPresident | Sell | 5.0k | $14.00 | $70k | Aug 14, 2026 |
| KAO JOHNChief Executive Officer | Sellindirect | 298.0k | $13.88 | $4.14M | Aug 10, 2026 |
| MARONEY DAWN CHRISTINEPresident | Exercise | 152.1k | $9.06 | $1.38M | Jul 15, 2026 |
| MARONEY DAWN CHRISTINEPresident | Sell | 177.1k | $20.83 | $3.69M | Jul 15, 2026 |
| KAO JOHNChief Executive Officer | Sellindirect | 298.0k | $19.81 | $5.92M | Jul 10, 2026 |
| KONOWIECKI JOSEPH SOfficer and Director | Sell | 25.0k | $24.00 | $600k | Jul 1, 2026 |
| HOCHRADEL SHANE JChief Operating Officer | Grant | 87.7k | — | — | Jul 1, 2026 |
| KONOWIECKI JOSEPH SOfficer and Director | Sell | 25.0k | $23.00 | $575k | Jun 26, 2026 |
| KONOWIECKI JOSEPH SOfficer and Director | Sell | 25.0k | $22.00 | $550k | Jun 18, 2026 |
| MARONEY DAWN CHRISTINEPresident | Sell | 30.0k | $19.55 | $586k | Jun 15, 2026 |
| KIM HYONG JOfficer | Sell | 36.0k | $19.86 | $714k | Jun 12, 2026 |
| KONOWIECKI JOSEPH SOfficer and Director | Sell | 25.0k | $21.00 | $525k | Jun 11, 2026 |
| KAO JOHNChief Executive Officer | Sellindirect | 298.0k | $19.65 | $6.07M | Jun 10, 2026 |
| KONOWIECKI JOSEPH SOfficer and Director | Grant | 122.8k | — | — | Jun 3, 2026 |
No analyst notes on ALHC yet.
Members whose judged calls on ALHC have played out most reliably.
No settled calls on ALHC yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
13 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 7 | 4 | 0 | 0 | Buy2.07 |
| 1 mo ago | 3 | 9 | 2 | 0 | 0 | Buy1.93 |
| 2 mo ago | 3 | 9 | 2 | 0 | 0 | Buy1.93 |
| 3 mo ago | 2 | 10 | 2 | 0 | 0 | Buy2.00 |